PACB - Pacific Biosciences of California Non-GAAP EPS of -$0.30 misses by $0.01 revenue of $36M in-line February, 15 2022 04:09 PM Pacific Biosciences of California Inc. Pacific Biosciences of California press release (NASDAQ:PACB): Q4 Non-GAAP EPS of -$0.30 misses by $0.01. Revenue of $36M in-line. Shares -3.3%. For further details see: Pacific Biosciences of California Non-GAAP EPS of -$0.30 misses by $0.01, revenue of $36M in-line